IITRI Announces New Flow Cytometry Services

IITRI is pleased to announce the addition of immunophenotyping services using flow cytometry to our ex vivo assay offerings. In flow cytometry, multiple properties can be analyzed simultaneously at the single cell level by generating a stream of cells in single-file...

IITRI Announces Expansion of Immunology Capabilities

IITRI is pleased to announce the expansion of our infectious disease immunology capabilities with the recent hiring of Justin Richner, PhD, to the position of Research Biologist, Viral Immunology. Dr. Richner’s research focus includes viral pathogenesis and host...
IITRI Chosen As Member of Nonclinical Studies Network

IITRI Chosen As Member of Nonclinical Studies Network

IITRI was one of 7 organizations chosen as a member of a Nonclinical Studies Network created by BARDA to aid in the successful development of medical countermeasures for biological threats. Nonclinical studies supporting treatments for biological threats is especially...
IITRI Awarded Over $4.7M BARDA Contracts

IITRI Awarded Over $4.7M BARDA Contracts

IITRI announces the recent award of three major new programs by the Biomedical Advanced Research and Development Authority (BARDA) valued at more than $4.7 M. The programs are for the development and/or evaluation of cutting edge technologies and agents to control...